Quick Takeaways
- Elizabeth A. Garofalo has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $922,663.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Elizabeth A. Garofalo and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | Director | $818,321 | -$41,560 | -4.8% | 02 Sep 2025 |
| ALEC | Alector, Inc. | Director | $104,342 | 11 Jun 2025 | ||
| XCUR | EXICURE, INC. | Director | 13 Jun 2022 | |||
| XENE | Xenon Pharmaceuticals Inc. | Director | 05 Jun 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|